Form 4: GoHealth CFO Jason Schulz Reports Stock and Option Grants
SEC Form 4 Filing
GoHealth's CFO, Jason Schulz, reports the grant of restricted stock units and stock options in a recent SEC filing.
Summary
- Jason Schulz, CFO of GoHealth, Inc., reported changes in beneficial ownership to the SEC on April 3, 2024.
- The report details the grant of 33,333 shares of Class A Common Stock as restricted stock units on April 1, 2024, vesting in three annual installments starting April 1, 2025.
- Schulz also received a grant of 16,667 stock options with an exercise price of $10.65 on April 1, 2024, also vesting in three annual installments beginning April 1, 2025.
- The filing also notes that Schulz owns 308,847 shares of Class A Common Stock directly, including shares purchased under the Employee Stock Purchase Plan.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, suggesting stability and alignment of interests. The sentiment is neutral to slightly positive.
Positives
- The grant of restricted stock units and stock options to the CFO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CFO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the granted equity.
Industry Context
Equity grants are a common practice in the healthcare and technology industries to incentivize and retain key executives.
Comparison to Industry Standards
- Equity compensation packages for CFOs in publicly traded companies typically include a mix of stock options, restricted stock units, and performance-based awards.
- The vesting schedules are fairly standard, often spanning three to four years to encourage long-term commitment.
- Comparable companies like SelectQuote or eHealth also utilize similar equity compensation strategies for their executive teams.
Stakeholder Impact
- Shareholders may view the equity grants as a positive sign, aligning management's interests with the company's long-term success.
- Employees may see the grants as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| May 16, 2022 | Date of original Power of Attorney appointing Brian Farley as attorney-in-fact for Jason Schulz. |
| September 25, 2023 | Date of Substitute Power of Attorney appointing Bradley Burd, Jennifer Cylinder, and Katherine OHalloran as substitute attorneys-in-fact. |
| June 30, 2023 | Date of Employee Stock Purchase Plan purchase of 1,421 shares. |
| December 31, 2023 | Date of Employee Stock Purchase Plan purchase of 545 shares. |
| April 1, 2024 | Date of transaction: Grant of restricted stock units and stock options. |
| April 1, 2025 | First vesting date for both restricted stock units and stock options. |
| April 3, 2024 | Date of SEC filing. |
| April 1, 2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.